Page 920 - Read Online

Mantovani et al. Hepatoma Res 2020;6:78 I http://dx.doi.org/10.20517/2394-5079.2020.75 Page 17 of 22

8. Adams LA, Anstee QM, Tilg H, Targher G. Non-alcoholic fatty liver disease and its relationship with cardiovascular disease and other
extrahepatic diseases. Gut 2017;66:1138-53.
9. Eslam M, Sanyal AJ, George J; International Consensus Panel. MAFLD: A Consensus-Driven Proposed Nomenclature for Metabolic
Associated Fatty Liver Disease. Gastroenterology 2020;158:1999-2014.e1.
10. Tilg H, Effenberger M. From NAFLD to MAFLD: when pathophysiology succeeds. Nat Rev Gastroenterol Hepatol 2020;17:387-8.
11. Fouad Y, Waked I, Bollipo S, Gomaa A, Ajlouni Y, Attia D. What’s in a name? Renaming ‘NAFLD’ to ‘MAFLD’. Liver Int 2020;40:1254-
61.
12. Portillo-Sanchez P, Bril F, Maximos M, et al. High Prevalence of Nonalcoholic Fatty Liver Disease in Patients With Type 2 Diabetes
Mellitus and Normal Plasma Aminotransferase Levels. J Clin Endocrinol Metab 2015;100:2231-8.
13. Kwok R, Choi KC, Wong GL, et al. Screening diabetic patients for non-alcoholic fatty liver disease with controlled attenuation parameter
and liver stiffness measurements: a prospective cohort study. Gut 2016;65:1359-68.
14. Arab JP, Barrera F, Gallego C, et al. High prevalence of undiagnosed liver cirrhosis and advanced fibrosis in type 2 diabetic patients. Ann
Hepatol 2016;15:721-8.
15. Jung CH, Lee B, Choi DH, et al. Association of grade of non-alcoholic fatty liver disease and glycated albumin to glycated hemoglobin
ratio in patients with type 2 diabetes mellitus. Diabetes Res Clin Pract 2017;125:53-61.
16. Masarone M, Rosato V, Aglitti A, et al. Liver biopsy in type 2 diabetes mellitus: Steatohepatitis represents the sole feature of liver
damage. PLoS One 2017;12:e0178473.
17. Petit JM, Pedro L, Guiu B, et al. Type 1 diabetes is not associated with an increased prevalence of hepatic steatosis. Diabet Med
2015;32:1648-51.
18. Wilman HR, Kelly M, Garratt S, et al. Characterisation of liver fat in the UK Biobank cohort. PLoS One 2017;12:e0172921.
19. Doycheva I, Cui J, Nguyen P, et al. Non-invasive screening of diabetics in primary care for NAFLD and advanced fibrosis by MRI and
MRE. Aliment Pharmacol Ther 2016;43:83-95.
20. Ding X, Xu Y, Wang Y, et al. Nonalcoholic fatty liver disease and associated metabolic risks of hypertension in type 2 diabetes: a cross-
sectional community-based study. Int J Endocrinol 2017;2017:5262560.
21. Al Rifai M, Silverman MG, Nasir K, et al. The association of nonalcoholic fatty liver disease, obesity, and metabolic syndrome, with
systemic inflammation and subclinical atherosclerosis: the Multi-Ethnic Study of Atherosclerosis (MESA). Atherosclerosis 2015;239:629-
33.
22. Williams KH, Burns K, Constantino M, et al. An association of large-fibre peripheral nerve dysfunction with non-invasive measures of
liver fibrosis secondary to non-alcoholic fatty liver disease in diabetes. J Diabetes Complications 2015;29:1240-7.
23. Cusi K, Sanyal AJ, Zhang S, et al. Non-alcoholic fatty liver disease (NAFLD) prevalence and its metabolic associations in patients with
type 1 diabetes and type 2 diabetes. Diabetes Obes Metab 2017;19:1630-4.
24. Guo K, Zhang L, Lu J, et al. Non-alcoholic fatty liver disease is associated with late but not early atherosclerotic lesions in Chinese
inpatients with type 2 diabetes. J Diabetes Complications 2017;31:80-5.
25. Herath HMM, Kodikara I, Weerarathna TP, Liyanage G. Prevalence and associations of non-alcoholic fatty liver disease (NAFLD) in Sri
Lankan patients with type 2 diabetes: A single center study. Diabetes Metab Syndr 2019;13:246-50.
26. Sberna AL, Bouillet B, Rouland A, et al. European Association for the Study of the Liver (EASL), European Association for the Study of
Diabetes (EASD) and European Association for the Study of Obesity (EASO) clinical practice recommendations for the management of
non-alcoholic fatty liver disease: evaluation of their application in people with Type 2 diabetes. Diabet Med 2018;35:368-75.
27. Krishan S. Correlation between non-alcoholic fatty liver disease (NAFLD) and dyslipidemia in type 2 diabetes. Diabetes Metab Syndr
2016;10:S77-81.
28. Su X, Xu J, Zheng C. The relationship between non-alcoholic fatty liver and skeletal muscle mass to visceral fat area ratio in women with
type 2 diabetes. BMC Endocr Disord 2019;19:76.
29. Vanjiappan S, Hamide A, Ananthakrishnan R, Periyasamy SG, Mehalingam V. Nonalcoholic fatty liver disease in patients with type 2
diabetes mellitus and its association with cardiovascular disease. Diabetes Metab Syndr 2018;12:479-82.
30. He X, Shen Y, Ma X, et al. The association of serum FGF23 and non-alcoholic fatty liver disease is independent of vitamin D in type 2
diabetes patients. Clin Exp Pharmacol Physiol 2018;45:668-74.
31. Kabir MA, Uddin MZ, Siddiqui NI, et al. Prevalence of non-alcoholic fatty liver disease and its biochemical predictors in patients with
type-2 diabetes mellitus. Mymensingh Med J 2018;27:237-44.
32. Lai LL, Wan Yusoff WNI, Vethakkan SR, Nik Mustapha NR, Mahadeva S, Chan WK. Screening for non-alcoholic fatty liver disease in
patients with type 2 diabetes mellitus using transient elastography. J Gastroenterol Hepatol 2019;34:1396-403.
33. Hashimoto Y, Osaka T, Fukuda T, Tanaka M, Yamazaki M, Fukui M. The relationship between hepatic steatosis and skeletal muscle mass
index in men with type 2 diabetes. Endocr J 2016;63:877-84.
34. Zou Y, Li X, Wang C, et al. Association between non-alcoholic fatty liver disease and peripheral artery disease in patients with type 2
diabetes. Intern Med J 2017;47:1147-53.
35. Afolabi BI, Ibitoye BO, Ikem RT, Omisore AD, Idowu BM, Soyoye DO. The relationship between glycaemic control and non-alcoholic
fatty liver disease in nigerian type 2 diabetic patients. J Natl Med Assoc 2018;110:256-64.
36. Moh Moh MA, Jung CH, Lee B, et al. Association of glucagon-to-insulin ratio and nonalcoholic fatty liver disease in patients with type 2
diabetes mellitus. Diab Vasc Dis Res 2019;16:186-95.
37. Cosma A, Cecchet D, Gaiani S, et al. Clinical and biochemical determinants of the extent of liver steatosis in type 2 diabetes mellitus. Eur
J Gastroenterol Hepatol 2015;27:1386-91.